List view / Grid view

Drug Markets

Multiple sclerosis therapeutics market to reach $20b by 2024

7 October 2015 | By Victoria White

The value of the multiple sclerosis therapeutics market will rise slowly from $17.2 billion in 2014 to approximately $20 billion by 2024...

news

Benign prostatic hyperplasia treatment market value to reach $5 billion by 2024

17 September 2015 | By Victoria White

The value of the global therapeutics market for benign prostatic hyperplasia will rise from $2 billion in 2014 to approximately $4.9 billion by 2024...

news

Allergic rhinitis treatment market to remain stagnant over next decade

9 September 2015 | By Victoria White

The value of the global treatment market for allergic rhinitis will witness minimal growth from $7.2 billion in 2014 to $7.3 billion by 2024, says research and consulting firm GlobalData...

news

Brazil’s pharmaceutical market to continue to prosper

25 August 2015 | By Victoria White

Brazil's pharmaceutical market will expand to reach approximately $47.9 billion by 2020, according to research and consulting firm GlobalData...

news

Growth hormone deficiency treatment market value to reach $1.88b by 2024

18 August 2015 | By European Pharmaceutical Review

The global market for growth hormone deficiency (GHD) treatment will rise in value from $1.26 billion in 2014 to reach approximately $1.88 billion by 2024, representing a moderate Compound Annual Growth Rate (CAGR) of 4.08%, according to research and consulting firm GlobalData.

news

Fabry disease treatment market value to reach $1.25b by 2024

6 August 2015 | By Victoria White

The global treatment market for Fabry disease will expand in value from $683 million in 2014 to approximately $1.25 billion by 2024...

news

Atezolizumab could spur bladder cancer treatment innovation

28 July 2015 | By Victoria White

Atezolizumab is poised to become a major bladder cancer therapy in the race for FDA approval, following its promising performance in recent Phase II trials...

news

J&J and Norvatis to fight it out in the axSpA treatment space

22 July 2015 | By Victoria White

Stelara has progressed into Phase III development for axSpA and, following its anticipated approval, is forecast to achieve sales of $244.7 million in 2024...

news

HerpV and GEN-003 will drive genital herpes treatment market growth to 2023

21 July 2015 | By Victoria White

The global market value for genital herpes therapeutics will increase from approximately $490 million in 2013 to just under $668 million by 2023, largely driven by the introduction of therapeutic vaccines, HerpV and GEN-003, towards the end of the forecast period, says research and consulting firm GlobalData.

news

Soliris could drive myasthenia gravis treatment market value beyond $550 million by 2024, says GlobalData

14 July 2015 | By Victoria White

The global market for myasthenia gravis therapeutics is anticipated to more than treble in value from $146.4 million in 2014 to $550.4 million by 2024...

news

Recent drug approvals will boost Parkinson’s disease therapeutics market

2 July 2015 | By Victoria White

The Parkinson’s disease treatment market value across eight major countries will reach $4.7 billion by 2022, says GlobalData...

news

Global gene therapy deals sky-rocketed to nearly $5 billion in 2014, says GlobalData

26 June 2015 | By Victoria White

The number of deals in the global gene therapy market more than doubled in 2014, with their combined value rising spectacularly to $4.9...

news

Viscosupplementation market value to exceed $2.6 billion by 2021, says GlobalData

25 June 2015 | By Victoria White

The viscosupplementation market value will increase to a little under $2.64 billion by 2021, across the ten major markets, says GlobalData...

news

Bristol-Myers Squibb will win big with melanoma combination immunotherapy

23 June 2015 | By Victoria White

Data presented at ASCO 2015 suggests that the Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape...

news

Axial spondyloarthritis treatment market value will almost double by 2024

11 June 2015 | By Victoria White

The global market value for axial spondyloarthritis therapeutics will expand from $1.5 billion in 2014 to reach $2.9 billion by 2024...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Drug Markets